Skip to main content
. 2019 Oct 29;25(2):e381–e385. doi: 10.1634/theoncologist.2019-0377

Table 1.

Baseline patient characteristics

Receipt of immunotherapy No (%) Yes (%) Total (%) Chi square
Total, n 9,014 (75) 2,930 (25) 11,944 (100)
Age <.001
<60 yr 2,885 (32) 1,217 (42) 4,102 (34)
≥60 yr 6,129 (68) 1,713 (58) 7,842 (66)
Gender .796
Male 6,102 (68) 1,991 (68) 8,093 (68)
Female 2,912 (32) 939 (32) 3,851 (32)
Race .425
Non‐Hispanic white 8,490 (94) 2,767 (94) 11,257 (94)
Non‐Hispanic black 133 (1) 35 (1) 168 (1)
Hispanic 238 (3) 70 (2) 308 (3)
Other 153 (2) 58 (2) 211 (2)
Facility area .001
Metropolitan 7,181 (80) 2,427 (83) 9,608 (80)
Urban 1,394 (15) 369 (13) 1,763 (15)
Rural 193 (2) 50 (2) 243 (2)
Unknown 246 (3) 84 (3) 330 (3)
Insurance <.001
Commercial 2,954 (33) 1,314 (45) 4,268 (36)
Medicare 4,535 (50) 1,208 (41) 5,743 (48)
Medicaid 711 (8) 194 (7) 905 (8)
Uninsured 486 (5) 105 (4) 591 (5)
Other 328 (4) 109 (4) 437 (4)
Zip code education level <.001
≥21% 1,309 (15) 300 (10) 1,609 (13)
13%–20.9% 2,250 (25) 690 (24) 2,940 (25)
7%–12.9% 3,083 (34) 1,032 (35) 4,115 (34)
<7% 2,345 (26) 903 (31) 3,248 (27)
Unknown 27 (<1) 5 (<1) 32 (<1)
Zip code income level <.001
<38,000 1,311 (15) 337 (12) 1,648 (14)
38,000–47,999 2,168 (24) 612 (21) 2,780 (23)
48,000–62,999 2,512 (28) 857 (29) 3,369 (28)
≥63,000 2,983 (33) 1,119 (38) 4,102 (34)
Unknown 40 (<1) 5 (<1) 45 (<1)
Facility type <.001
Nonacademic 5,367 (60) 1,297 (44) 6,664 (56)
Academic 3,215 (36) 1,404 (48) 4,619 (39)
Unknown 432 (5) 229 (8) 661 (6)
Facility location <.001
East 1,591 (18) 622 (21) 2,213 (19)
South 3,317 (37) 880 (30) 4,197 (35)
Central 2,042 (23) 669 (23) 2,711 (23)
West 1,632 (18) 530 (18) 2,162 (18)
Unknown 432 (5) 229 (8) 661 (6)
Distance to treatment facility <.001
≤40 miles 7,334 (81) 2,229 (76) 9,563 (80)
>40 miles 1,645 (18) 693 (24) 2,338 (20)
Unknown or missing 35 (<1) 8 (<1) 43 (<1)
Charlson Deyo score <.001
0 6,662 (74) 2,410 (82) 9,072 (76)
1 1,608 (18) 398 (14) 2,006 (17)
2 484 (5) 91 (3) 575 (5)
3 260 (3) 31 (1) 291 (2)
Surgery to metastatic site .03
No 6,542 (73) 2,068 (71) 8,610 (72)
Yes 2,404 (27) 829 (28) 3,233 (27)
Unknown 68 (1) 33 (1) 101 (1)
Brain metastasis <.001
None 4,544 (50) 1,480 (51) 6,024 (50)
Present 2,425 (27) 632 (22) 3,057 (26)
Unknown 2,045 (23) 818 (28) 2,863 (24)
Liver metastasis <.001
None 5,441 (60) 1,605 (55) 7,046 (59)
Present 1,474 (16) 505 (17) 1,979 (17)
Unknown 2,099 (23) 820 (28) 2,919 (24)
Lung metastasis <.001
None 4,036 (45) 1,111 (38) 5,147 (43)
Present 2,893 (32) 999 (34) 3,892 (33)
Unknown 2,085 (23) 820 (28) 2,905 (24)
Bone metastasis <.001
None 5,646 (63) 1,697 (58) 7,343 (61)
Present 1,287 (14) 416 (14) 1,703 (14)
Unknown 2,081 (23) 817 (28) 2,898 (24)
Receipt of chemotherapy <.001
No 6,094 (68) 2,549 (87) 8,643 (72)
Yes 2,620 (29) 336 (11) 2,956 (25)
Unknown 300 (3) 45 (2) 345 (3)
Receipt of radiotherapy <.001
No 5,695 (63) 1,736 (59) 7,431 (62)
Yes 3,166 (35) 1,184 (40) 4,350 (36)
Unknown 153 (2) 10 (<1) 163 (1)
Year of diagnosis <.001
2011 1,859 (21) 341 (12) 2,200 (18)
2012 1,811 (20) 356 (12) 2,167 (18)
2013 1,881 (21) 559 (19) 2,440 (20)
2014 1,801 (20) 707 (24) 2,508 (21)
2015 1,662 (18) 967 (33) 2,629 (22)
Radiation modality <.001
None 5,695 (63) 1,736 (59) 7,431 (62)
External beam radiation therapy 2,405 (27) 772 (26) 3,177 (27)
Stereotactic 719 (8) 390 (13) 1,109 (9)
Other 42 (<1) 22 (1) 64 (1)
Unknown 153 (2) 10 (<1) 163 (1)
Radiation treatment volume <.001
None 5,695 (63) 1,736 (59) 7,431 (62)
Central nervous system 2,032 (23) 751 (26) 2,783 (23)
Mediastinum 118 (1) 49 (2) 167 (1)
Liver and pancreas 9 (<1) 7 (<1) 16 (<1)
Bone 368 (4) 140 (5) 508 (4)
Skin and soft tissue 129 (1) 45 (2) 174 (1)
Other sites 480 (5) 175 (6) 655 (5)
Unknown 183 (2) 27 (1) 210 (2)

graphic file with name ONCO-25-e381-g001.jpg